- Home
- CLYM vs SOL Comparison
CLYM vs SOL Comparison
Compare CLYM & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLYM
- SOL
- Stock Information
- Founded
- CLYM 2018
- SOL 2005
- Country
- CLYM United States
- SOL United States
- Employees
- CLYM N/A
- SOL N/A
- Industry
- CLYM
- SOL Semiconductors
- Sector
- CLYM
- SOL Technology
- Exchange
- CLYM NYSE
- SOL Nasdaq
- Market Cap
- CLYM 84.5M
- SOL 94.9M
- IPO Year
- CLYM 2021
- SOL 2008
- Fundamental
- Price
- CLYM $1.23
- SOL $1.78
- Analyst Decision
- CLYM Buy
- SOL Strong Buy
- Analyst Count
- CLYM 1
- SOL 2
- Target Price
- CLYM $10.00
- SOL $4.50
- AVG Volume (30 Days)
- CLYM 201.7K
- SOL 171.8K
- Earning Date
- CLYM 08-13-2025
- SOL 05-14-2025
- Dividend Yield
- CLYM N/A
- SOL N/A
- EPS Growth
- CLYM N/A
- SOL N/A
- EPS
- CLYM N/A
- SOL N/A
- Revenue
- CLYM N/A
- SOL $85,621,000.00
- Revenue This Year
- CLYM N/A
- SOL N/A
- Revenue Next Year
- CLYM N/A
- SOL $45.37
- P/E Ratio
- CLYM N/A
- SOL N/A
- Revenue Growth
- CLYM N/A
- SOL N/A
- 52 Week Low
- CLYM $1.05
- SOL $1.04
- 52 Week High
- CLYM $9.21
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- CLYM N/A
- SOL 57.66
- Support Level
- CLYM N/A
- SOL $1.69
- Resistance Level
- CLYM N/A
- SOL $1.79
- Average True Range (ATR)
- CLYM 0.00
- SOL 0.09
- MACD
- CLYM 0.00
- SOL -0.01
- Stochastic Oscillator
- CLYM 0.00
- SOL 51.79
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.